• Mutation; VGNC; VGNC:38514; BRAF; None_reported; -; Zygosity=- (PubMed=24035468).
  

PubMed=15585963; DOI=10.1292/jvms.66.1437
Kaori Inoue, Emi Ohashi, Tsuyoshi Kadosawa, Sung-Hyeok Hong, Satoru Matsunaga, Manabu Mochizuki, Ryohei Nishimura, Nobuo Sasaki;
Establishment and characterization of four canine melanoma cell lines.
J. Vet. Med. Sci. 66:1437-1440(2004)

PubMed=24035468; DOI=10.1016/j.tvjl.2013.08.003
Keita Ito, Masato Kobayashi, Shiori Kuroki, Yu Sasaki, Taisuke Iwata, Kohei Mori, Tetsuya Kuroki, Yuta Ozawa, Masanori Tetsuka, Tomoko Nakagawa, Teruyo Hiroi ...Show all 15 authors... , Hitomi Yamamoto, Kenichiro Ono, Tsukimi Washizu, Makoto Bonkobara; Show fewer authors
The proteasome inhibitor bortezomib inhibits the growth of canine malignant melanoma cells in vitro and in vivo.
Vet. J. 198:577-582(2013)

PubMed=28283079; DOI=10.1016/j.tvjl.2017.02.001
Ryohei Yoshitake, Kohei Saeki, Matanobu Watanabe, Nanako Nakaoka, Siew Mei Ong, Masakazu Hanafusa, Nan Choisunirachon, Naoki Fujita, Ryohei Nishimura, Takayuki Nakagawa;
Molecular investigation of the direct anti-tumour effects of nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell lines.
Vet. J. 221:38-47(2017)

PubMed=30268330; DOI=10.1016/j.tvjl.2018.09.001
Ryo Miyamoto, Sena Kurita, Hiroyuki Tani, Tomoyo Ikeda, Mio Ishizaka, Hono Saima, Masato Kobayashi, Kyoichi Tamura, Makoto Bonkobara;
Canine squamous cell carcinoma cell lines with high expression of survivin are sensitive to survivin inhibitor YM155.
Vet. J. 240:31-36(2018)